~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
Clinical trials of a new drug cocktail have been shown to cure 58 percent of terminally-ill patients by shrinking cancerous tumors or eliminating them altogether. The scientific community is hailing this discovery as a major breakthrough in cancer research.
The new cocktail is a form of immunotherapy, a relatively new class of drugs that harness the body’s immune system to extinguish fatal tumors. Israeli researcher Prof. Jacob Schachter, who took part in the development of the drug and in the recent clinical trials, told Israel’s Channel 10 that the newfound drug cocktail could serve as the basis of treatment for many types of cancer, potentially replacing chemotherapy. “It’s an explosion,” he said.
In one of the trials, over half of the terminally ill patients saw their tumors shrink or disappear completely.
Continue reading